Company Overview
Tuberculosis Tuberculosis and HIV
Other Infectious Diseases |
Company Overview
Founded in 2000, Chemogen
is a privately held company focused on developing
novel proprietary tests for the diagnosis of infectious
diseases, initially tuberculosis.
Chemogen’s scientific team, led by Dr.
Vladimir Koulchin, has developed a revolutionary urine-based
TB diagnostic test, capable of accelerating TB detection
and playing an important role in eradicating tuberculosis
while opening significant market opportunities worldwide.
Chemogen’s technology is adaptable to multiple existing
diagnostic formats.
Chemogen’s
test demonstrates better performance than the current
standard of sputum microscopy
in those co-infected with TB and HIV. The test is highly
effective in screening for active TB in HIV-positive individuals,
and is significantly easier to use than competing technologies. |
